Are Analysts Expecting A Better 2020 For China SXT Pharmaceuticals Inc. (SXTC)?


    Hudson Bay Capital Management LP has recently announced that it has increased stake in China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) by 2.40%. After grabbing 2.2 million shares, the institutional investor is now in possession of 51579.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.94% having worth around $0.87 million. Moreover, Acadian Asset Management LLC increased its share by 0.99 million to have a control over 1.01 million shares. And Renaissance Technologies LLC raised its holdings to 0.33 million shares by acquiring 0.93 million shares or 3.35% of the stake.

    China SXT Pharmaceuticals Inc. (SXTC) concluded trading on 08/27/20 at a closing price of $0.33, with 1.12 million shares of worth about $0.37 million changed hands on the day. Weekly performance of the stock remained negative as price took a plunge of -14.88% during that period and on Thursday the price saw a loss of about -2.28%. Currently the company’s common shares owned by public are about 27.73M shares.

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) started trading at $0.3399, above $0.01 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $0.33, or with a loss of -2.28%. Stock saw a price change of -14.88% in past 5 days and over the past one month there was a price change of -24.19%. Year-to-date (YTD), SXTC shares are showing a performance of -60.24% which decreased to -86.37% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.32 but also hit the highest price of $2.80 during that period. While comparing its average daily trading volume of 6.42 million shares, we see that about 1.12 million changed hands on the day. The stock is currently trading -13.99% below its 20-day simple moving average (SMA20), while that difference is down -27.77% for SMA50 and it goes to -48.79% lower than SMA200.

    Hudson Bay Capital Management LP acquired 2.2 million shares of China SXT Pharmaceuticals Inc. having value of about $0.87 million. Data submitted at the U.S SEC by Hudson Bay Capital Management LP revealed that the firm now holds 51579.0 shares in the company valued at close to $17021.07, or have control over 2.40% stake in the company. China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) currently have 27.73M outstanding shares and institutions hold larger chunk of about 15.24% of that. Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.

    The stock has a current market capitalization of $9.04M. It has posted earnings per share of -$0.42 in the same period. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SXTC, volatility over the week remained 7.29% while standing at 7.68% over the month.

    Analysts at 0 brokerage firms have issued recommendations for the China SXT Pharmaceuticals Inc. (SXTC)’s stock out of those 0 Wall Street analysts, 0 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.


    Please enter your comment!
    Please enter your name here